Fate Therapeutics, Inc. News Headlines

FATE 
$3.855
*  
0.375
8.87%
Get FATE Alerts
*Delayed - data as of Nov. 24, 2014 12:51 ET  -  Find a broker to begin trading FATE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    FATE Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Fate Therapeutics (FATE) Catches Eye: Stock Adds 6.4% in Session - Tale of the Tape
11/19/2014 9:11:00 AM - Zacks.com


SUPN Revises Revenue Outlook Upward, EVDY Fit And Fine, NASDAQ Warning For ACST
11/11/2014 10:40:00 PM - RTT News


SUPN Revises Revenue Outlook Upward, EVDY Fit And Fine, NASDAQ Warning For ACST
11/11/2014 10:40:00 PM - RTT News


After-Hours Earnings Report for November 11, 2014 : FOSL, YY, TAHO, HMIN, LXFT, STKL, AERI, MGNX, SUPN, PFIE, FATE, CLSN
11/11/2014 2:00:03 PM - NASDAQ.com News


Fate Reports In-Line Loss in Q4 - Analyst Blog
3/20/2014 1:28:01 PM - Zacks.com


Fate Therapeutics' Prohema in Phase II Study - Analyst Blog
3/13/2014 10:50:01 AM - Zacks.com


2 Speculative Biotechs For The 'Shotgun Investor'
10/29/2013 11:12:00 AM - Seeking Alpha


Insiders Buy Shares at Fate Therapeutics and ChemoCentryx
10/8/2013 2:05:00 PM - Minyanville


Fate Therapeutics: You Need A Lot Of Faith Investing In This Public Offering
10/2/2013 12:54:00 PM - Seeking Alpha


Fate Therapeutics prices IPO at $6, at low end of the revised range
10/1/2013 7:38:04 AM - Renaissance Capital


Orphan disease biotech Fate Therapeutics decreases range and increases shares offered
9/30/2013 9:46:46 AM - Renaissance Capital


9 US IPOs planned for the week of Sep 30
9/30/2013 7:00:03 AM - Renaissance Capital


13 U.S. IPOs Planned For The Week Of September 23
9/24/2013 8:38:00 AM - Seeking Alpha


13 US IPOs planned for the week of Sep 23
9/23/2013 7:00:04 AM - Renaissance Capital


IPO Preview: Fate Therapeutics
9/18/2013 6:28:00 PM - Seeking Alpha


12 U.S. IPOs Planned For The Week Of September 16
9/16/2013 3:57:00 PM - Seeking Alpha


12 US IPOs planned for the week of Sep 16
9/16/2013 10:47:34 AM - Renaissance Capital


U.S. IPO Recap: Benefitfocus, Six Others Set Terms As Calendar Rebuilds
9/10/2013 8:21:00 AM - Seeking Alpha


Orphan disease biotech Fate Therapeutics sets terms for $60 million IPO
9/3/2013 7:46:29 AM - Renaissance Capital


U.S. IPO Recap: Regado Slashes Valuation, 3 Deals Added To IPO Pipeline
8/26/2013 2:56:00 PM - Seeking Alpha


U.S. IPO Recap: 2013 Breaks Past 2012's IPO Totals In Pricings And Filings
8/19/2013 1:47:00 PM - Seeking Alpha


Orphan disease biotech Fate Therapeutics files for a $69 million IPO
8/14/2013 8:01:32 AM - Renaissance Capital